TrialClinical and translational science2026
Ligelizumab Immunogenicity and Impact on Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety in Patients With Chronic Spontaneous Urticaria.
Yan Ji et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.